by Jennifer McCormack | Mar 12, 2020 | Connected Health, Health, Healthcare, Medtech, Medtech, Pharma/Bio
“The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.” BCC Research – ROI in Pharmaceutical R&D: How to Halt the Decline BCC...
by Darren Kelly | Jan 24, 2020 | Healthcare, Pharma/Bio
“At present, neurodegenerative diseases represent one of the main causes of death in the industrialized economy. Overall characterized by a loss of neurons in particular regions of the nervous system, the subsequent decline in cognitive and motor function that...
by Darren Kelly | Jan 16, 2020 | Healthcare, Pharma/Bio
The global enterprise imaging market is estimated at $933.7 million in 2018. The market is picking up pace in developed countries and other major geographies that have high penetration of radiology and cardiology PACS, enterprise-level VNA and electronic health...
by Darren Kelly | Jan 9, 2020 | Healthcare, Pharma/Bio
“The global dermatology drugs market is expected to grow from $66.8 billion in 2018 to $97.5 billion in 2022 at a CAGR of 9.9%” Dermatology Drugs Market Competitor Briefing 2019 – BCC Research BCC Research Dermatology Drugs Market Competitor Briefing 2019 EBSCO...
by caroline price | Feb 21, 2019 | Food/Beverages, Pharma/Bio
Enterprise Ireland clients can access a variety of databases covering numerous markets at the Market Research Centre. Below are just some of the vitamin and dietary supplements market reports available. BCC Research Over-the-counter (OTC) Drugs and Dietary...
by caroline price | Sep 4, 2018 | Healthcare, Pharma/Bio
“Type 2 diabetes patients are estimated to make up 90-95% of the total diabetes population” Diabetes Type 2; Introduction, Datamonitor Healthcare Enterprise Ireland clients can access Datamonitor Healthcare’s in-depth analysis on the Diabetes Type 2,...
